Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infection

Explore clinical trials studying Meningococcal Infection. Study availability and eligibility vary by location and protocol.

23 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infection trial results

Active, not recruiting

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

NCT07135986

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • Investigational Site Number : 1561000 Nanning, Guangxi, China
  • Investigational Site Number : 1561001 Jingxi, China
  • Investigational Site Number : 1561003 Liuzhou, China
  • Investigational Site Number : 1561002 Tengzhou, China
View Trial Details
Completed

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

NCT06228586

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • Investigational Site Number : 7040001 Hanoi, Vietnam
  • Investigational Site Number : 7040002 Thái Bình, Vietnam
  • Investigational Site Number : 7040003 Thái Bình, Vietnam
  • Investigational Site Number : 7040004 Thái Bình, Vietnam
View Trial Details
Completed

A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years

NCT02531698

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Helsinki South Vaccine Research Clinic Helsinki, Finland
  • Oulu Vaccine Research Clinic Oulu, Finland
  • Pori Vaccine Research Clinic Pori, Finland
View all 15 locations
View Trial Details
Completed

Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

NCT01543087

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC Chandler, Arizona, United States
  • Clinical Research Advantage, Inc./ East Valley Family Physicians, PLC Chandler, Arizona, United States
  • St. Joseph Heritage Healthcare Huntington Beach, California, United States
  • Center For Clinical Trials, LLC Paramount, California, United States
View all 56 locations
View Trial Details

Related conditions